B-cell receptor recognizing Neisseria meningitidis serogroup A, C, W, and Y capsular polysaccharides (BCR)

B-cell receptors (BCRs) recognizing Neisseria meningitidis serogroup A, C, W, and Y capsular polysaccharides are specialized membrane-bound immunoglobulins found on the surface of B lymphocytes. These receptors play a critical role in the adaptive immune system by identifying and binding to the specific carbohydrate structures that form the protective capsule of the meningococcus bacterium (Goldschneider et al., 1969). Upon binding these polysaccharides—often presented as part of a conjugate vaccine—the BCR initiates a signaling cascade that leads to B-cell activation, proliferation, and differentiation into memory B cells and plasma cells. This process is essential for the production of protective IgG antibodies that facilitate the opsonization and complement-mediated bactericidal killing of the pathogen (UniProt, 2024). In the context of meningococcal disease, these receptors are the primary targets for quadrivalent (A, C, W, Y) vaccines, which aim to establish long-term immunity against invasive infections such as meningitis and septicemia (CDC, 2023). The interaction between the vaccine antigen and the BCR is the fundamental step in generating a protective humoral response, making these receptors central to the efficacy of meningococcal prophylaxis. Successful engagement of these receptors results in the generation of high-affinity antibodies that can be measured via serum bactericidal assays to confirm protection (Pollard et al., 2009).

Other names

Surface immunoglobulinsIgB-lymphocyte receptorAntigen-specific B-cell receptorAnti-meningococcal BCR

The vaccine antigens bind to the B-cell receptors (BCRs) specific for the A, C, W, and Y polysaccharides. This binding, particularly when the polysaccharides are conjugated to a carrier protein, triggers BCR signaling and receptor-mediated endocytosis. The B cell then processes the antigen and presents peptide fragments to T-helper cells, leading to robust B-cell proliferation, isotype switching to IgG, and the formation of long-lived memory B cells and plasma cells that secrete bactericidal antibodies (Pollard et al., 2009; CDC, 2023).